Johnson & Johnson will not be undertaking local trials for its single-shot COVID-19 vaccine in India.
That's according to a report in The Economic Times on Tuesday, citing a company spokesperson.
While J&J had sought approval for conducting bridging trials in the country, the US-based drugmaker said it wouldn't have to do that now since India has scrapped that requirement,
The company is exploring how to accelerate the availability of its vaccine in India, the newspaper added.


Trump says deal reached to disarm Hamas, Israeli support for plan remains uncertain
Kuwait says Iranian attack hits Chinese company building, kills one
Japan quake snarls auto and chip supply chains as toll hits 34
Indian federal police file charges against 13 over exam paper leaks
